Australasian Diabetes Congress 2025

ADS Plenary Speaker

Michael Roden is chairman/professor of endocrinology and metabolic disorders at Heinrich-Heine University Düsseldorf, head of the Department of Medical Clinics and director of its Division of Endocrinology and Diabetology at University Hospital Düsseldorf, Germany. He is also CEO of the German Diabetes Center (DDZ), the Leibniz Center for Diabetes Research and one speaker of the German Centers of Diabetes Research (DZD). He was trained at University of Vienna, Austria, and Yale University, New Haven, CT. His translational research addresses energy metabolism in obesity, diabetes and comorbidities, with one focus on steatotic liver disease, as well as diabetes subtyping. Roden has made major contributions to our understanding of the mechanisms of nutrient-induced insulin resistance, the role of mitochondria adaptation in MASLD/MASH and to diabetes subtype-specific risk of complications, thereby facilitating precision diabetology. He is author of 700+ peer-reviewed publications (e. g. in Nature, Lancet, Cell Metab…) and highly cited researcher (Clarivate 2022, 2023). He received several awards (e. g. Oskar-Minkowski Prize by EASD, G. B. Morgagni Gold Medal by University of Pisa, Paul-Langerhans Medal by the German Diabetes Association, DDG), holds honorary doctorates of the Universities of Athens and Belgrade and is honorary member of the Hungarian Diabetes Association. Roden was chairman of EFSD, honorary treasurer of EASD and EFSD and president of the Central European and Austrian Diabetes Associations. From 2016-2021, he served as head of the Committee Medicine of the German Council of Science and Humanities, appointed by the President of Germany. Recently, he has been elected as collaborative professor of Kanasawa University, Japan, and member of the Academia Europea and the German National Academy of Sciences Leopoldina.